Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study

BACKGROUND: According to EULAR recommendations, biologic DMARDs (bDMARDs) such as tumor necrosis factor inhibitor, tocilizumab (TCZ), and abatacept (ABT) are in parallel when prescribing to rheumatoid arthritis (RA) patients who have shown insufficient response to conventional synthetic DMARDs. Howe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arthritis Res Ther
Asıl Yazarlar: Nakamura, Seiji, Suzuki, Katsuya, Iijima, Hiroshi, Hata, Yuko, Lim, Chun Ren, Ishizawa, Yohei, Kameda, Hideto, Amano, Koichi, Matsubara, Kenichi, Matoba, Ryo, Takeuchi, Tsutomu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4952232/
https://ncbi.nlm.nih.gov/pubmed/27435242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1052-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller